• Dr. Michael Hanaway joined the UAB Division of Transplantation in February 2005. A native of Wisconsin, Dr. Hanaway received his undergraduate degree from the University of Wisconsin, and proceeded to medical school at the University of Wisconsin, graduating in 1992. He completed his surgical residency in general surgery at the University of Wisconsin in 1997, and returned after a year of research at Duke University to complete his multi-organ transplant fellowship in 2000. Dr. Hanaway began his surgical career at the University of Cincinnati before coming to UAB in 2005. Dr. Hanaway is a specialist in kidney and pancreas transplantation as well as live donor surgery. Dr. Hanaway is the Surgical Director of the Kidney Transplant Program at UAB, and oversees all aspects of the program, with particular attention to pre-transplant evaluation. Dr. Hanaway has served on UNOS committees including the Membership and Professional Standards Committee. Dr. Hanaway is reviewer for the American Journal of Transplantation, Transplantation and The American Journal of Surgery.

    Dr. Hanaway’s clinical interests include kidney and pancreas transplantation. His surgical focus is primarily on kidney transplantation and laparoscopic live donor nephrectomy. Over the past 15 years, Dr. Hanaway has performed a high volume of laparoscopic donor nephrectomies and has one of the largest experiences in the U.S. Dr. Hanaway’s research interest has focused on induction therapy in kidney transplantation.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 Perpetuating Disparity: Failure of the Kidney Transplant System to Provide the Most Kidney Transplants to Communities With the Greatest NeedAnnals of Surgery.  276:597-604. 2022
    2022 Greater community vulnerability is associated with poor living donor navigator program fidelitySurgery.  172:997-1004. 2022
    2022 Abnormal time-zero histology is predictive of kidney transplant outcomesClinical Transplantation.  36. 2022
    2021 Impact of Social Vulnerability on Access to Educational Programming Designed to Enhance Living Donation 2021
    2021 Self-advocacy is associated with lower likelihood of living donor kidney transplantation 2021
    2021 Effects of Geographic Redistribution Policy on Access to Organ Transplant-In ReplyJAMA Surgery.  156:289-290. 2021
    2021 Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the United StatesTransplantation.  1904-1908. 2021
    2020 Exacerbating Racial Disparities in Kidney Transplant: The Consequences of Geographic RedistributionJAMA Surgery.  155:679-681. 2020
    2020 Combined Thoracic-Kidney Transplantation Practices May Exacerbate Existing Geographic Disparities in Access to Deceased Donor Kidney TransplantationJournal of Heart and Lung Transplantation.  39:S366-S367. 2020
    2020 Clinical pig kidney xenotransplantation: How close are we?Journal of the American Society of Nephrology.  31:12-21. 2020
    2020 Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living-donor Kidney TransplantationTransplantation.  122-129. 2020
    2020 Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center ExperienceAnnals of Surgery.  271:177-183. 2020
    2019 Patient Perspectives on Weight Management for Living Kidney DonationJournal of Surgical Research.  244:50-56. 2019
    2019 Donation approval among obese living kidney donor candidates: The impact of metabolic syndromeSurgery.  166:940-946. 2019
    2019 Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney ChainAnnals of Surgery.  270:639-646. 2019
    2018 Population Health, Ethnicity, and Rate of Living Donor Kidney TransplantationTransplantation.  102:2080-2087. 2018
    2015 Preoperative arterial microcalcification and clinical outcomes of arteriovenous fistulas for hemodialysisAmerican Journal of Kidney Diseases.  66:84-90. 2015
    2013 Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patientsAmerican Journal of Kidney Diseases.  62:1122-1129. 2013
    2013 Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomesClinical Journal of the American Society of Nephrology.  8:1750-1755. 2013
    2011 Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturationAmerican Journal of Kidney Diseases.  58:437-443. 2011
    2011 The authors replyNew England Journal of Medicine.  365:671-672. 2011
    2011 Alemtuzumab induction in renal transplantationNew England Journal of Medicine.  364:1909-1919. 2011
    2008 Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patientsClinical Transplantation.  22:113-119. 2008
    2007 Temporary silastic mesh closure for adult liver transplantation: A safe alternative for the difficult abdomenLiver Transplantation.  13:258-265. 2007
    2006 Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantationTransplant International.  19:295-302. 2006
    2005 Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: A matched control studyClinical Transplantation.  19:711-716. 2005
    2005 Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: The Israel Penn International Transplant Tumor Registry experienceAmerican Journal of Transplantation.  5:775-780. 2005
    2005 United Network for Organ Sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data [4]Transplantation.  79:623. 2005
    2005 African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppressionAmerican Journal of Transplantation.  5:356-365. 2005
    2005 Laparoscopic donor nephrectomy vs. open live donor nephrectomy: A quality of life and functional studyClinical Transplantation.  19:102-109. 2005
    2005 A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: The cincinnati experienceTransplantation Proceedings.  37:802-803. 2005
    2005 Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppressionTransplantation Proceedings.  37:800-801. 2005
    2005 Chemotherapy for posttransplant lymphoproliferative disorder: The Israel Penn International Transplant Tumor Registry ExperienceTransplantation Proceedings.  37:956-957. 2005
    2005 Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapyTransplantation Proceedings.  37:795-797. 2005
    2005 De novo colorectal cancer: Five-year survival is markedly lower in transplant recipients compared with the general populationTransplantation Proceedings.  37:960-961. 2005
    2005 Donor kidneys with small renal cell cancers: Can they be transplanted?Transplantation Proceedings.  37:581-582. 2005
    2005 Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: Multivariate analysis of risk factors for acute rejectionTransplantation Proceedings.  37:798-799. 2005
    2005 Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosisTransplantation Proceedings.  37:817-818. 2005
    2005 Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantationTransplantation Proceedings.  37:812-813. 2005
    2005 Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimensTransplantation Proceedings.  37:809-811. 2005
    2005 Laparoscopic living donor nephrectomy for kidneys with multiple arteriesTransplantation Proceedings.  37:629-630. 2005
    2005 Laparoscopic right living donor nephrectomyTransplantation Proceedings.  37:631-632. 2005
    2005 Methicillin-resistant Staphylococcus aureus infection in liver transplantation: A matched controlled studyTransplantation Proceedings.  37:1243-1244. 2005
    2005 Pilot study of early corticosteroid elimination after pancreas transplantationTransplantation Proceedings.  37:1287-1288. 2005
    2005 Posttransplant lymphoproliferative disorder: Significance of central nervous system involvementTransplantation Proceedings.  37:954-955. 2005
    2005 Prostate cancer prior to solid organ transplantation: The Israel Penn International Transplant Tumor Registry ExperienceTransplantation Proceedings.  37:958-959. 2005
    2005 Risk for recurrence and death from preexisting cancers after transplantationTransplantation Reviews.  19:151-163. 2005
    2005 Skin cancer following transplantation: The Israel Penn International Transplant Tumor Registry experienceTransplantation Proceedings.  37:962-963. 2005
    2004 Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: A report from the Israel penn international transplant tumor registryTransplantation.  78:1676-1682. 2004
    2004 Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancerDiseases of the Colon and Rectum.  47:1898-1903. 2004
    2004 Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphomaTransplantation.  78:972-977. 2004
    2004 Right donor nephrectomy: A comparison of hand-assisted transperitoneal and retroperitoneal laparoscopic approachesTransplantation.  77:521-525. 2004
    2004 West Nile virus encephalitis in organ transplant recipients: Another high-risk group for meningoencephalitis and death?Transplantation.  77:466-469. 2004
    2004 Donor transmitted malignancies. 2004
    2004 Posttransplant malignancy 2004
    2003 Donors with central nervous system malignancies: Are they truly safe?Transplantation.  76:340-343. 2003
    2003 MALToma: A Helicobacter pylori-associated malignancy in transplant patients: A report from the Israel Penn International Transplant Tumor Registry with a review of published literatureTransplantation.  75:225-228. 2003
    2003 Maximizing renal artery length in right laparoscopic donor nephrectomy by retrocaval exposure of the aortorenal junctionTransplantation.  75:83-85. 2003
    2002 Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional laparoscopic living-donor nephrectomyAmerican Journal of Transplantation.  2:983-988. 2002
    2002 Incidental diagnosis of gastric cancer in transplant recipients improves patient survivalSurgery.  132:754-760. 2002
    2002 De novo breast cancer in renal transplant recipientsTransplantation Proceedings.  34:1778-1779. 2002
    2002 De novo sarcomas in solid organ transplant recipientsTransplantation Proceedings.  34:1786-1787. 2002
    2002 Gastric cancer in transplant recipients: Detection of malignacy by aggressive endoscopyTransplantation Proceedings.  34:1784-1785. 2002
    2002 Immunosuppression and merkel cell cancerTransplantation Proceedings.  34:1780-1781. 2002
    2002 Polyomavirus in kidney and kidney-pancreas transplantation: A defined protocol for immunosuppression reduction and histologic monitoringTransplantation Proceedings.  34:1788-1789. 2002
    2002 Surgical techniques in right laparoscopic donor nephrectomyJournal of the American College of Surgeons.  195:131-137. 2002
    2002 The role of immunosuppression in lymphoma.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.  159:55-66. 2002
    2002 Transplantation without steroidsTransplantation Proceedings.  34:2076-2078. 2002
    2001 Biologic behavior of carcinoid tumors in solid organ transplant recipients: The Israel Penn international transplant tumor registry experienceTransplantation Proceedings.  33:3656-3657. 2001
    2001 Kaposi sarcoma: An analysis of the US and international experiences from the Israel Penn international transplant tumor registryTransplantation Proceedings.  33:3660-3661. 2001
    2001 Are concerns over right laparoscopic donor nephrectomy unwarranted?Annals of Surgery.  233:645-651. 2001
    2001 Is any method of vascular control superior in hepatic resection of metastatic cancers?: Longmire clamping, pringle maneuver, and total vascular isolationJAMA Surgery.  136:569-575. 2001
    2001 Laparoscopic live donor nephrectomy: Rationale, techniques, and implicationsSeminars in Dialysis.  14:365-372. 2001
    2001 Transmission of donor cancer into cardiothoracic transplant recipientsSurgery.  130:660-668. 2001
    2000 The role of anti-Galα1-3Gal antibodies in acute vascular rejection and accommodation of xenograftsTransplantation.  70:1667-1674. 2000
    2000 Long-term results of liver transplantation in patients 60 years of age and olderTransplantation.  70:780-783. 2000
    1998 The promise of xenograftingAdvances in Chronic Kidney Disease.  5:299-308. 1998
    1997 Split tolerance induced by immunotoxin in a rhesus kidney allograft modelTransplantation.  63:1339-1345. 1997
    1997 FN18-CRM9 immunotoxin promotes tolerance in primate renal allograftsTransplantation.  63:1-6. 1997
    1996 Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft modelTransplantation.  61:1222-1228. 1996


    Year Title Altmetric
    2006 Malignancy after pancreas transplantation.  191-201. 2006
    2005 Transplant-Related Malignancies.  1149-1164. 2005

    Research Overview

  • induction therapy in kidney transplantation
  • Principal Investigator On

    Investigator On

  • APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients  awarded by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine ^
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Deceased Donor Kidney Transplantation  awarded by Johns Hopkins University
  • Impact of CCR5 Blockade in HIV + Kidney Transplant Recipients  awarded by University of California, San Francisco
  • Impact of CCR5 Blockade in HIV+Kidney Transplant Recipients  awarded by University of California, San Francisco
  • Kidney Transplantation in Recipients and Donors with HIV: Long Term Follow up Study  awarded by Johns Hopkins University
  • Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors  awarded by Northwestern University
  • Preserving Renal Function & Protective Immunity via Anti-LFA-1-Based CNI Avoidance  awarded by Emory University
  • Private Grant  awarded by ASTELLAS PHARMA US, INC.
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by PROTEON THERAPEUTICS, INC.
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by QUARK PHARMACEUTICALS, INC.
  • Private Grant  awarded by PROTEON THERAPEUTICS, INC.
  • Private Grant  awarded by ASTELLAS PHARMA US, INC.
  • Education And Training

  • University of Wisconsin Hospital & Clinics, Internship
  • University of Wisconsin Hospital & Clinics, Residency
  • University of Wisconsin Hospital & Clinics, Postdoctoral Fellowship
  • Doctor of Medicine, University of Wisconsin System : Madison 1991
  • Full Name

  • Michael Hanaway